1-3 of 3
Pablo Cabral, MSc
Close
Sort by
Journal Articles

Synthesis and Preliminary Assessment of 99m tc-HYNIC-Fab´s (Rituximab) for Non-Hodgkin Lymphoma Diagnosis

Ximena Camacho, MSc, Camila Machado, Agustina Banchero, MD, Maria Fernanda García, MSc, Victoria Calzada, MSc, Marcelo Fernández, BSc, María Moreno, PhD, Juan Pablo Gambini, MD PhD, Omar Alonso, MD PhD, Roger Chammas, MD PhD, Pablo Cabral, MSc, PhD, Eloísa Riva, MD
Journal: Blood
Blood (2014) 124 (21): 5373.
https://doi.org/10.1182/blood.V124.21.5373.5373
Published: 2014
Journal Articles

99m. Tc-Rituximab as Radiotracer For Molecular Imaging In Non Hodgkin Lymphoma

Ximena Camacho, MSc, Agustina Banchero, MD, Maria Fernanda García, MSc, Marcelo Fernández, BSc, Natalia Oddone, BSc, María Moreno, PhD, Cecilia Guillermo, MD, Juan Pablo Gambini, MD, PhD, Pablo Cabral, MSc, PhD, Eloísa Riva, MD
Journal: Blood
Blood (2013) 122 (21): 3026.
https://doi.org/10.1182/blood.V122.21.3026.3026
Published: 2013
Journal Articles

Development of 99mTcHYNIC-Tocilizumab as Imaging Agent In Multiple Myeloma

Eloísa Riva, MD, Victoria Calzada, BSc, Eugenia Gutiérrez, Marcelo Fernández, BSc, Natalia Oddone, BSc, María Moreno, PhD, Juan Benech, PhD, José A. Chabalgoity, PhD, Atanasio Pandiella, Sr., MD, PhD, Pablo Cabral, MSc
Journal: Blood
Blood (2010) 116 (21): 4081.
https://doi.org/10.1182/blood.V116.21.4081.4081
Published: 2010